English
español
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10261/42259
Share/Impact:
Statistics |
![]() ![]() ![]() |
|
|
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |||
|
Title: | Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas |
Authors: | Moreno-Bueno, Gema ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Keywords: | Basal-like carcinomas Breast cancer EMT LOXL2 Metastasis |
Issue Date: | Sep-2011 |
Publisher: | Wiley-Blackwell European Molecular Biology Organization |
Citation: | EMBO Molecular Medicine 3(9): 528-544 (2011) |
Abstract: | Basal-like breast carcinoma is characterized by the expression of basal/myoepithelial markers, undifferentiated phenotype, highly aggressive behaviour and frequent triple negative status (ESR−, PR−, Her2neu−). We have previously shown that epithelial–mesenchymal transition (EMT) occurs in basal-like breast tumours and identified Lysyl-oxidase-like 2 (LOXL2) as an EMT player and poor prognosis marker in squamous cell carcinomas. We now show that LOXL2 mRNA is overexpressed in basal-like human breast carcinomas. Breast carcinoma cell lines with basal-like phenotype show a specific cytoplasmic/perinuclear LOXL2 expression, and this subcellular distribution is significantly associated with distant metastatic incidence in basal-like breast carcinomas. LOXL2 silencing in basal-like carcinoma cells induces a mesenchymal-epithelial transition (MET) associated with a decrease of tumourigenicity and suppression of metastatic potential. Mechanistic studies indicate that LOXL2 maintains the mesenchymal phenotype of basal-like carcinoma cells by a novel mechanism involving transcriptional downregulation of Lgl2 and claudin1 and disorganization of cell polarity and tight junction complexes. Therefore, intracellular LOXL2 is a new candidate marker of basal-like carcinomas and a target to block metastatic dissemination of this aggressive breast tumour subtype. |
Publisher version (URL): | http://dx.doi.org/10.1002/emmm.201100156 |
URI: | http://hdl.handle.net/10261/42259 |
DOI: | 10.1002/emmm.201100156 |
ISSN: | 1757-4676 |
E-ISSN: | 1757-4684 |
Appears in Collections: | (IIBM) Artículos (IBIS) Artículos |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | ![]() View/Open |
Show full item record
Review this work
Review this work
Related articles:
WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.